|
Originally published In Press as doi:10.1074/jbc.M103831200 on June 18, 2001
J. Biol. Chem., Vol. 276, Issue 34, 32230-32239, August 24, 2001
Shigella Invasion of Macrophage
Requires the Insertion of IpaC into the Host Plasma Membrane
FUNCTIONAL ANALYSIS OF IpaC*
Asaomi
Kuwae,
Sei
Yoshida,
Koichi
Tamano,
Hitomi
Mimuro,
Toshihiko
Suzuki, and
Chihiro
Sasakawa
From the Department of Microbiology and Immunology, Institute of
Medical Science, University of Tokyo, 4-6-1 Shirokanedai,
Minato-ku, Tokyo 108-8639, Japan
Received for publication, April 30, 2001, and in revised form, June 4, 2001
 |
ABSTRACT |
Shigella infects residential
macrophages via the M cell entry, after which the pathogen induces
macrophage cell death. The bacterial strategy of macrophage infection,
however, remains largely speculative. Wild type Shigella
flexneri (YSH6000) invaded macrophages more efficiently than the
noninvasive mutants, where YSH6000 induced large scale lamellipodial
extension including ruffle formation around the bacteria. When
macrophages were infected with the noninvasive ipaC mutant,
the invasiveness and induction of membrane extension were dramatically
reduced as compared with that of YSH6000. J774 macrophages infected
with YSH6000 showed tyrosine phosphorylation of several proteins
including paxillin and c-Cbl, and this pattern was distinctive from
those stimulated by Salmonella typhimurium or phorbol
ester. Upon addition of IpaC into the external medium of macrophages,
membrane extensions were rapidly induced, and this promoted uptake of
Escherichia coli. The exogenously added IpaC was found to
be integrated into the host cell membrane as detected by
immunostaining. The IpaC domain required for the induction of membrane
extension from J774 was narrowed down within the region of residues
117-169, which contains a putative membrane-spanning sequence. Our
data indicate that Shigella directs its own entry into
macrophages, and the IpaC domain which is required for the association
with its host membrane is crucial.
 |
INTRODUCTION |
Shigella are highly adapted human pathogens that cause
bacillary dysentery, a disease provoking severe bloody and mucus
diarrhea. When Shigella reach the colon, the bacteria are
translocated through the epithelial barrier by way of the M cells which
overlay the solitary lymphoid nodules (1-3). Once they reach the
underlying M cells, Shigella infect the resident macrophages
and induce cell death (4). Meanwhile the pathogens released from the
killed macrophages enter into enterocytes from the basolateral surface by inducing membrane ruffles and macropinocytosis. Once the bacterium is surrounded by a membrane vacuole, it immediately disrupts the vacuole to escape into the cytoplasm (5). Within the cytoplasm, Shigella can multiply and move by inducing actin
polymerization at one pole of the bacterium, which allows intracellular
spreading of the bacterium within the cytoplasm as well as into the
adjacent epithelial cells (6, 7). Thus, the predominant feature of the
Shigella pathogenicity is the ability to infect macrophage and epithelial cells, resulting in dissemination to adjacent epithelial cells.
A genetic study revealed that Shigella invasion of
epithelial cells requires the numerous genes encoded by the 31-kilobase pair pathogenicity island on the large 230-kilobase pair plasmid (8).
The pathogenicity island of Shigella flexneri contains 28 invasion-associated genes arranged in several transcribed regions (9).
One of these contains the ipa genes whose products such as
IpaA, IpaB, IpaC, and IpaD are required for bacteria-cell interactions including induction of macropinocytosis from epithelial cells, whereas
the mxi and spa regions are mostly involved in
the formation of the type III secretion machinery (10-12).
Studies have indicated that Shigella-induced
macropinocytosis in epithelial cells occurs through a complicated
process requiring the interaction of the type III-secreted effector
proteins and host factors. In this process, the Ipa proteins (IpaA-D)
are thought to play the most important roles. However, the involvement
of Ipa proteins in the Shigella entry into epithelial cells
is complicated and still unclear. Some of the Ipa proteins act both as
regulators of the type III secretion system as well as effector
proteins within the host cells. For example, IpaB and IpaD act as the
molecular plug for regulating the type III secretion system (13-15).
In addition, IpaB and IpaC, as well as Salmonella SipB and
SipC (16) and Yersinia YopB and YopD (17), serve as a
membrane pore in part of the type III machinery of the host cell plasma
membrane, allowing the translocation of secreted effector proteins into
the host cells (18). Upon contact to epithelial cells, a massive amount of IpaB and IpaC proteins is also secreted into the external medium from Shigella and promotes bacterial invasion by interacting
with putative host receptors such as
5 1 integrin and CD44 (19, 20).
However, these interactions would still be insufficient to elicit the
macropinocytic events in epithelial cells required for bacterial entry.
Further large scale rearrangement of actin dynamism is assumed to
require a second signaling event within the host cytoplasm through the
delivery of IpaA, IpaC, and IpgD via the type III secretion machinery
(21, 22). IpaA binds to vinculin, and the IpaA-vinculin complex
together with F-actin promotes depolymerization of actin filaments
required for modification of Shigella-induced membrane
protrusions (23, 24). IpaC somehow modulates actin dynamism, since
formation of filopodia and lamellipodia can be induced when purified
IpaC protein is added to semipermeabilized Swiss 3T3 cells or a
ipaC clone is transfected into HeLa cells. The IpaC-induced
membrane protrusions have been implicated in the activation of Cdc42
which in turn activates Rac1 (25). Although the mechanisms of
IpaC-induced membrane protrusions are unknown, these studies have
suggested that IpaC can somehow act as the effector for promoting
Shigella invasion of epithelial cells.
Many invasive pathogenic bacteria have a specific strategy to resist
the bactericidal activities of macrophages. For example, upon contact
to macrophages, Yersinia activates the type III secretion system and delivers a set of Yop proteins into the cell (26-28). The
injected Yop proteins such as YopE, YopH, YopT, YopO, and YopP act in
various ways to prevent phagocytosis and kill the macrophages, such as
inducing destruction of actin filaments, interfering with cell signal
transduction, or provoking apoptosis (29). Salmonella
induces a macropinocytic event from epithelial cells and macrophages
and delivers a subset of effector proteins from the type III secretion
system encoded by the Salmonella pathogenicity island I, and
then the pathogen can enter both types of cells. In the infection of
macrophages, however, the pathogen eventually induces apoptosis to kill
the cells (30, 31), for which SipB encoded by Salmonella
pathogenicity island I is delivered into macrophages (32, 33).
Salmonella typhimurium possesses an additional type III
secretion system encoded by the Salmonella pathogenicity
island II, which is activated inside the infected macrophage and
delivers proteins such as SpiC and SifA that are required for bacterial
proliferation in phagosomes and their maintenance (34, 35).
Shigella infects macrophages and disrupts the phagocytic vacuoles to escape into the cytoplasm, from which the bacterium later
induces the cell death (36). A previous study (4) indicated that
internalized Shigella induced macrophage apoptosis
after 1-2 h postinfection, in which IpaB protein secreted via the type III secretion system within the macrophage cytoplasm played a crucial
role. However, some other studies indicated that macrophage killing by
apoptosis could only be induced if the cells were activated such as by
stimulating with interferon- (37, 38). Whenever Shigella
elicits different killing systems from the infected macrophages, the
cell death results in release of massive amounts of interleukin-1 , thus triggering a strong inflammatory response (39), and leads to an
increase in the permeability of the epithelial barrier to Shigella entry and the migration of
PMN1 (40, 41).
Therefore, elucidation of the bacterial strategy for infection of
macrophages is an important issue for understanding the pathogenicity
of Shigella and for the development of novel attenuated vaccines that are still invasive but do not induce macrophage cell
death. Nevertheless, the molecular basis for infection of macrophages
by Shigella still remains poorly understood. Hence, we
decided to investigate whether the pathogen had the ability to direct
its own internalization into macrophages and induce the activation of
macrophage functions. Our data strongly indicate that
Shigella directs its own phagocytic events in macrophages by
exploiting the ability of IpaC to be integrated into the host membrane.
In this study, we provide direct evidence for the first time indicating
that the membrane-spanning IpaC domain is critical for the inducing
macropinocytic event in macrophages.
 |
EXPERIMENTAL PROCEDURES |
Bacterial Strains, Cell Culture, Plasmids, and
Media--
S. flexneri 2a YSH6000 is the wild type strain,
and S325 is a mxiA::Tn5 derivative of
YSH6000 used as the negative control deficient in the type III
secretion activity (42). S. typhimurium SB300 was obtained
from J. E. Galan (Yale School of Medicine, New Haven, CT).
Escherichia coli MC1061 was used as the host for constructing various plasmids. pBluescript SK+ (Stratagene), pGEX-2T (Amersham Pharmacia Biotech), pCACTUS-Tpr (43), and
pMW119Tp (44) were used for genetic engineering experiments. E. coli JM109 was used as the host for constructing pQE-30
(Qiagen)-borne plasmids. All primers used for construction of the
various plasmids are listed in Table I.
Strains containing pMW119Tp- or pCACTUS-Tpr-based plasmids
were grown in Muller-Hinton broth (Difco) when selection for
trimethoprim resistance was necessary. For all macrophage infection
experiments, overnight cultures of the bacterial strains were diluted
50-fold in brain-heart infusion broth (Difco) and incubated at 37 °C
for 2 h. J774 cells (ATCC TIB-67) and THP-1 cells (ATCC TIB-202)
were maintained in RPMI 1640 (Sigma), and RAW264.7 cells (ATCC TIB-71)
were maintained in Dulbecco's modified Eagle's medium (Sigma). For
the preparation of HMDM, monocytes were isolated from the peripheral
blood of healthy donors using Ficoll-Paque (Amersham Pharmacia Biotech)
following the manufacturer's protocol. The separated mononuclear cells
were plated on coverslips, and nonadherent cells were removed after
1 h of incubation. The medium was then replaced by fresh RPMI 1640 containing 10% FBS and 50 ng/ml human recombinant
granulocyte-macrophage colony-stimulating factor (PeproTech).
Monocytes were cultivated for 5-7 days, and the adherent population
was shown to be >95% macrophages as determined morphologically by
Giemsa's stain.
Preparation of Antibodies--
The antibodies specific for IpaB,
IpaC, and IpaD used for the immunoblots have been described previously
(45). A fusion protein of IpaC tagged with six histidine residues at
the N terminus was constructed using the QIAexpress system with a
pQE-30 plasmid. A DNA fragment including the ipaC gene was
amplified by PCR using an ipaC-1 primer containing a
BamHI site and an ipaC-2 primer containing a SalI
site together with pMYSH6000, the large virulence plasmid in YSH6000 as
the template. The amplified BamHI-SalI fragment was cloned into pQE-30, resulting in the plasmid pQE-ipaC-fl. The
fusion IpaC protein purified by nickel-nitrilotriacetic acid chromatography (Qiagen) was used to immunize rabbits. The anti-IpaC whole molecule antiserum was incubated with nitrocellulose membrane containing transferred fusion IpaC protein, and the Ig fraction specific for the whole molecule of IpaC (anti-IpaC-wm) was eluted. IpaC
peptides named IpaC-n, encompassing amino acid residues 35-55 (ISTKQTQSSSETQKSQNYQQI), IpaC-m, encompassing amino
acid residues 140-169 (RTAETKLGSQLSLIAFDATKSAAENIVRQG), and
IpaC-c, encompassing amino acid residues 228-247
(KQIDTNITSPQTNSSTKFLG), were synthesized. The anti-IpaC whole
molecule antiserum was incubated with IpaC-n-, IpaC-m- or
IpaC-c-conjugated, epoxy-activated Sepharose 6B (Amersham Pharmacia
Biotech) to obtain an Ig fraction specific for each peptide; the
antibodies obtained were named anti-IpaC-n, anti-IpaC-m, and
anti-IpaC-c, respectively.
Gentamicin Protection Assay--
The invasion efficiency of
bacteria was measured with a gentamicin protection assay (46). Briefly,
a 24-well tissue culture plate (Costar) was seeded with 2 × 105 cells/well and incubated overnight at 37 °C under
5% CO2. Each well was then infected at an m.o.i. of ~500
for 30 min, before prewarmed tissue culture medium containing
gentamicin was added at a final concentration of 200 µg/ml. After a
15-min incubation, the medium was removed, and the macrophages were
washed three times with PBS. PBS containing 0.5% Triton X-100 was then
added to each well in order to lyse the cells. After an appropriate dilution with saline, the lysed solution was plated onto L agar, and
the number of viable bacteria was counted.
Immunostaining Assay--
Immunostaining was performed
essentially as described previously (47). Mac-1 and Fc R were labeled
with the anti-Mac-1 mAb M1/70 (BIOSOURCE
International, Inc.) or the anti-Fc R mAb 2.4G2 (PharMingen),
respectively. The anti-rat IgG antibody conjugated with fluorescein
isothiocyanate (Sigma) was used as the secondary antibody. In order to
measure the invasive capacity of the bacteria by immunostaining, the
number of bacteria internalized in the macrophage cytoplasm was
counted as follows: J774 cells seeded on coverslips were infected at an
m.o.i. of ~30 and centrifuged for 10 min at 900 × g.
The infected J774 cells were then incubated for 15 min at 37 °C
under 5% CO2. Next the cells were washed with PBS and then
fixed for 15 min with PBS containing 4% paraformaldehyde. The fixed
cells were incubated in PBS containing anti-Shigella LPS
antiserum for 1 h. To visualize extracellular bacteria, the cells
were washed and then incubated with anti-rabbit IgG conjugated to
fluorescein isothiocyanate (Sigma). To visualize intracellular bacteria, the cells were washed again and permeabilized by incubation with PBS containing 0.2% Triton X-100 for 20 min at room temperature. The cells were then treated once more with the anti-Shigella
LPS antiserum and incubated with anti-rabbit IgG conjugated to Cy5 (Amersham Pharmacia Biotech). Immunostained samples were examined by
confocal laser scanning microscopy (Radiance Plus, Bio-Rad).
Measurement of Spread in J774 Cells Infected with
Shigella--
J774 cells seeded on coverslips were infected at an
m.o.i. of ~500 before being centrifuged for 10 min and incubated for
30 min at 37 °C under 5% CO2. The cells were then
washed with PBS and fixed in PBS containing 4% paraformaldehyde. The
fixed cells were stained with Giemsa's solution. Photographs of the
cells were taken with a CCD camera on the microscope, and the cell
areas were measured using IPLab Spectrum software (Signal Analytics Corp.).
Scanning Electron Microscopy--
Macrophages were grown on
12-mm round coverslips (Matsunami) before being infected by
centrifugation as described above. For further fixation, the washed and
fixed cells were treated with 2% OsO4 and then processed
for electron microscopy as described by Ginocchio et al.
(48). Visualization of samples was carried out by an S800 scanning
electron microscope (Hitachi).
Generation of a Nonpolar ipaC Mutant and pIpaC--
For
construction of a nonpolar mutant of ipaC, the
aphA-3 (kanamycin resistance gene) cassette was used (49).
Purified pMYSH6000 was used as the template for PCR. Nonpolar mutants
of ipaC were constructed as follows: a DNA fragment
encompassing nucleotides from position 1226 upstream of the 5' end of
the ipaC gene to nucleotide 215 downstream from the 5' end
was amplified by PCR using primers icm-1 containing an ApaI
site and icm-2 containing an SmaI site. The
ApaI-SmaI fragment was cloned into pBluescript, resulting in the plasmid pipaC-u. Another DNA fragment encompassing nucleotides from position 1076 downstream from the 5' end of the ipaC gene to nucleotide 2494 downstream from the 5' end was
amplified using primers icm-3 containing an SmaI site and
icm-4 containing a BamHI site. The
SmaI-BamHI fragment was then cloned into pipaC-u, yielding the plasmid pipaC-ud. The aphA-3 cassette was
cloned at the SmaI site of pipaC-ud in the correct
orientation, resulting in the plasmid
pBSipaC::Kmr. The inactivated
ipaC gene digested from
pBSipaC::Kmr at ApaI and
NotI sites was subcloned into pCACTUS-Tpr,
followed by introduction of the resultant plasmid named
pipaC::Kmr into YSH6000 by
electroporation. Integration and selection of nonpolar ipaC
mutants were achieved as described previously (43), and the obtained
mutant strain, ipaC, was named TK001. For complementation of the ipaC gene defect in TK001, pIpaC was constructed by
cloning the DNA fragment containing the ipaC gene into
pMW119Tp. This fragment was amplified by PCR using primer icc-1 and
icc-2 with pMYSH6000 as the template.
Analysis of Effector Protein Expression and Secretion--
The
effector protein solution released in the Shigella culture
supernatants following stimulation with Congo red and the whole bacterial lysate were prepared as described previously (43). Each
protein sample from the same number of bacteria was separated by 12%
SDS-PAGE and immunoblotted with anti-IpaB, anti-IpaC, and anti-IpaD antibody.
Phosphotyrosine--
J774 cells were seeded on 6-well tissue
culture plates (Costar) at a concentration of 4 × 105
cells/well and incubated overnight at 37 °C under 5%
CO2. Shigella and Salmonella strains
were added at an m.o.i. of ~500 and centrifuged for 10 min. COZ, IOZ,
or BOZ was prepared as described previously (50, 51). Opsonized zymosan
particles were centrifuged onto the macrophage (particle:cell
ratio = 10:1) for 2 min. Treatment of macrophage with PMA (Sigma)
was carried out at a final concentration of 100 ng/ml. After various
incubation times, the cells were washed twice with ice-cold PBS and
then lysed in 50 µl of lysis buffer (10 mM Tris-HCl, pH
7.6, 5 mM EDTA, 50 mM NaCl, 30 mM
sodium pyrophosphate, 50 mM NaF, 1% Triton X-100, 100 mM Na3VO4, 1 mM
phenylmethylsulfonyl fluoride, 1 mg/ml pepstatin A, 10 mg/ml leupeptin)
per well. The cell lysates were sonicated for 10 s and clarified
by centrifugation at 15,000 × g for 15 min. The
supernatants were then assayed for protein concentration with SDS-PAGE.
The supernatants were incubated with anti-PY mAb 4G10 (Upstate
Biotechnology Inc.), anti-paxillin mAb 349 (Transduction Laboratories),
or anti-c-Cbl antibody C-15 (Santa Cruz Biotechnology).
Immunoprecipitations were performed overnight at 4 °C. Protein
G-Sepharose (Sigma) was used for precipitation of the immunocomplexes.
The anti-PY antibody RC20 (Transduction Laboratories) was used for
detection of phosphotyrosine proteins by immunoblot analysis. In the
case of zymosan phagocytosis measured at 0, 15, 30, and 45 min, protein
tyrosine phosphorylation was maximum at 15 min after addition (data not shown).
Sequential Observation of Macrophage Morphology--
J774 or
HMDM were seeded on 35-mm dishes. The cells were washed twice with
prewarmed RPMI medium without FBS, and then medium containing 1/10th
volume of recombinant protein solution prepared at 5 µM
was added. Macrophage shape was observed with an Axiovert 135 microscope (Zeiss) equipped with a SenSys 1400 CCD camera (Roper
Scientific) in chamber maintained at 37 °C with a 5%
CO2 atmosphere.
Phagocytosis Assay--
The bacterial pellet of E. coli HB101 grown to middle log phase was suspended in the FBS-free
RPMI medium containing recombinant protein at a final concentration of
0.5 µM. Preparation of J774 cells and the phagocytosis
assay were carried out under almost the same conditions as described
for the gentamicin protection assay mentioned above. The cell medium
was replaced with 0.5 ml/well RPMI without FBS prior to addition of the
bacterial suspension. The bacterial pellet was added at an m.o.i. of
~1000 for 15 min. After gentamicin treatment for 30 min, the
internalized bacteria were recovered and spread onto L-agar plates.
Construcion of GST-VirA, GST-IpaD, and IpaC Deletion
Plasmids--
The DNA fragments containing virA or
ipaD gene amplified by PCR using primers virA-1 and virA-2
or ipaD-1 and ipaD-2, respectively, were cloned into pGEX-2T. After the
purification under native conditions and digestion with thrombin
according to the manufacturer's instructions, the GST fusion protein
was dialyzed against Tris-buffered saline. pQE-ipaC-fl was digested
with SacI and HindIII or StuI and
HindIII in order to obtain the plasmids designated
pQE-ipaC- C1 (containing the coding region of IpaC amino acid
residues 1-284) or pQE-ipaC- C4 (containing the coding region of
IpaC amino acid residues 1-169), respectively. After digestion, the
DNA fragments containing the pQE-30 sequence were recovered from
agarose gel and filled in using T4 DNA polymerase (Toyobo) followed by
ligation. To obtain the plasmids named pQE-ipaC- NC (containing the
coding region of IpaC amino acid residues 117-284) and pQE-ipaC- CTM (containing the C1 deleted with coding region of IpaC amino acid residues 117-169), the DNA fragments were amplified by PCR using primers NC-1 and NC-2 or CTM-1 and CTM-2, respectively, together with
pQE-ipaC- C1 as a template. These DNA fragments were digested with
BamHI (for construction of pQE-ipaC- NC) or
SalI (for construction of pQE-ipaC- CTM) and then ligated.
To obtain the plasmid named pQE-ipaC- C8 (containing the coding
region of IpaC amino acid residues 1-112), the DNA fragment was
amplified by PCR using pQE-ipaC-fl as a template and primers C8-1 and
C8-2. This DNA fragment was then digested with SalI, and
the amplified fragment was ligated. These pQE-30-based plasmids were
introduced into the E. coli JM109 strain, and the strains
harboring pQE-ipaC- C1, pQE-ipaC- C4, pQE-ipaC- NC,
pQE-ipaC- CTM, and pQE-ipaC- C8 expressing the truncated IpaC
fusion proteins tagged with six histidine were designated C1, C4,
NC, CTM, and C8, respectively. All histidine-tagged fusion
protein was dialyzed against Tris-buffered saline after the
purification under native conditions according to the manufacturer's protocol.
 |
RESULTS |
Invasive Shigella Enters the Macrophage More Efficiently Than the
Noninvasive Mutant--
To investigate whether the invasive S. flexneri would be able to direct internalization into macrophages,
macrophage cell lines such as J774, RAW264.7, and THP-1 were infected
with YSH6000 (wild type S. flexneri) or S325 (a noninvasive
mutant deficient in the type III secretion system). At 30 min after the
addition of bacteria, fresh medium containing gentamicin was added to
the cultures and incubated for a further 15 min. The internalized bacteria were counted by plating the cell lysates on agar revealing that the numbers of YSH6000 internalized into J774, THP-1, and RAW264.7
were 7-, 5-, and 2 times higher than that of S325, respectively (Fig.
1A). Although the number of
internalized bacteria varied among cell lines, the bacterial number
associated with each cell line after cytochalasin D treatment showed no
substantial differences between YSH6000 and S325 (data not shown). To
ensure further the difference in bacterial invasive capacity, J774
cells infected with YSH6000 or S325 were fixed, and the internalized
bacteria were immunostained with anti-Shigella LPS antiserum
and anti-rabbit IgG conjugated with Cy5 (see "Experimental
Procedures"). As shown in Fig. 1B, the number of
internalized YSH6000 was significantly higher (~10 times) than that
of S325. These results suggest that wild type S. flexneri
directs its own internalization into macrophages.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 1.
Invasiveness of S. flexneri
into macrophage cell lines. A represents the
relative number of internalized YSH6000 (wild type, closed
bars) and S325 (mutant, open bars) into J774, THP-1, or
RAW264.7 cells as measured by the gentamicin protection assay.
Error bars represent S.E. from triplicate experiments.
B, immunofluorescence staining of J774 infected with YSH6000
or S325 strains. Cy5, fluorescein isothiocyanate, and
rhodamine-phalloidin signals represent intracellular bacteria
(red), extracellular bacteria (green), and
F-actin (blue), respectively.
|
|
Shigella Invasion of Macrophages Elicits Cell Spreading--
J774
infected with YSH6000 or S325 were stained by Giemsa's solution, and
the cell morphology was investigated using microscopy. As shown in Fig.
2A, S325 was observed
associated with macrophages; however, some of the macrophages infected
with YSH6000 showed remarkable cellular spreading. Typically, the
average area of cells infected with YSH6000 (157.0 ± 4.9 µm2, n = 301) was significantly higher
than that with S325 (71.0 ± 1.3 µm2,
n = 303) or that of cells without infection (72.9 ± 1.1 µm2, n = 305). Scanning electron
microscopy confirmed that J774 infected with YSH6000 extended a large
scale lamellipodium (Fig. 2B). Also in some cases, infection
of HMDM by YSH6000 (Fig. 2B) or J774 by YSH6000 (data not
shown), membrane ruffles protruded and surrounded the bacteria.
However, no J774 or HMDM cells infected with S325 showed such cellular
responses, suggesting that S. flexneri has the ability to
induce a large scale membrane extension including formation of
lamellipodia and membrane ruffles in macrophages.

View larger version (51K):
[in this window]
[in a new window]
|
Fig. 2.
Photographs of macrophages infected with
invasive (wild type) or noninvasive (mutant) Shigella.
A, Giemsa-stained J774 cells after infection with YSH6000
(wild type), S325 (mutant), or uninfected cells. The
histograms represent the distribution of cell numbers
according to the areas (mm2) measured by >300 cells.
B, scanning electron microscopy of J774 or HMDM infected
with YSH6000 or S325. Right lower panel is an enlargement of
the left side panel.
|
|
IpaC Is Essential for Efficient Uptake of Shigella by
Macrophages--
So far, studies have indicated that IpaC plays the
most central role in inducing macropinocytic events in invasion of
epithelial cells by Shigella (25). Hence, we constructed a
nonpolar ipaC mutant (TK001) based on YSH6000 and introduced
the wild type ipaC clone (pIpaC) into TK001. The ability of
YSH6000, TK001, TK001/pIpaC, or S325 to secrete IpaB, IpaC, and IpaD
into medium was investigated using a conditional medium (PBS containing
30 µg/ml of Congo red) to stimulate the type III secretion activity.
As shown in Fig. 3A, although
the effectors such as IpaA and IpgD could still be secreted from TK001
at similar levels to those from YSH6000 or TK001/pIpaC, no IpaC was
secreted from TK001 at all. An immunoblot with anti-IpaB, IpaC, and
IpaD antibodies showed that IpaB and IpaD but not IpaC were present in
the whole cell lysate from TK001, confirming that TK001 is deficient in
IpaC production. We thus investigated TK001 together with TK001/pIpaC,
YSH6000, and S325 for their invasive capacity into J774 using the
gentamicin-protection assay. The ability of TK001 to enter macrophages
was reduced to less than 20% that of the wild type level (Fig.
3C). The reduced invasive capacity of TK001 was restored by
the introduction of pIpaC (Fig. 3C). The appearance of cell
spreading as well as the scale of lamellipodium by TK001 was also
remarkably decreased as compared with that of YSH6000 (Fig.
3C). Fig. 3D shows a typical example of spreading
by J774 cells infected with YSH6000, in which the cell dramatically
spread as extending cell periphery with membrane ruffles and evoked
local F-actin condensation around bacteria. J774 infected with YSH6000
or TK001 at 15 min after infection was subsequently investigated for
the accumulation of Fc R and Mac-1 (CR3,
M 2 integrin), since they are the major phagocytic receptors involved in uptake of particles or bacteria and
depend on the rearrangement of the actin cytoskeleton (52-54). As
shown in Fig. 3E, Fc R accumulated around the area of
entry with YSH6000, but this was not observed with TK001. Mac-1 also accumulated but locally at the sites where YSH6000 was associated with
J774, and thus Mac-1 foci were also present at the adhesion points
along the spreading cell periphery (Fig. 3F). The results of
these experiments strongly suggest that secreted IpaC is critical for
inducing the phagocytic event that promotes Shigella
invasion of macrophages.

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
Infection properties of the
nonpolar ipaC mutant (TK001) and its complemented
mutant (TK001/pIpaC) in macrophage infection. A,
Coomassie Brilliant Blue (CBB) staining of a SDS-PAGE gel
shows the proteins secreted from YSH6000 (wild type), TK001,
TK001/pIpaC, or S325 (mxiA::Tn5)
strains by adding Congo red (CR). Numbers to the
right indicate the molecular weight standards. B,
immunoblot analysis of the Ipa proteins secreted from YSH6000, TK001,
TK001/pIpaC, or S325 using anti-IpaB, IpaC, and IpaD antibodies.
C, invasiveness and inducibility of cell spreading in J774
cells. Invasion efficiency was quantified by the gentamicin protection
assay, whereas cell spreading was defined as being over 150 µm2 in area. Error bars represent S.E. from
triplicate experiments. D, J774 infected with YSH6000
(a), TK001 (b), or TK001/pIpaC (c) for
15 min were stained with anti-Shigella LPS antiserum
(blue) and rhodamine-phalloidin (red).
E and F, J774 infected with YSH6000 or TK001 for
15 min were stained with anti-Shigella LPS antiserum
(blue) and anti-Fc R (E) or anti-Mac-1
(F) antibodies (green). The arrows in
E, a and b, or F, a and b
mark Fc R or Mac-1 clustering, respectively. The position of the
focal plane showed as apical and basal sections in F
represent the bacterial contact site and the cell adhesion points of
substrata, respectively. The arrowheads in F, c,
mark the Mac-1 foci.
|
|
Tyrosine Phosphorylation of Macrophage Proteins Induced by
Shigella--
Fc R-mediated phagocytosis and Mac-1-mediated cell
adhesions have been shown to stimulate host protein tyrosine
phosphorylation (55-57). To assess whether the phagocytic events
including macrophage spreading induced by Shigella would
also involve protein tyrosine phosphorylation, J774 infected with
YSH6000 or TK001 at various times were examined for protein tyrosine
phosphorylation by immunoprecipitation and immunoblotting with anti-PY
antibodies. At 15 min post-infection of J774 with YSH6000 but not with
TK001, proteins corresponding to the molecular masses of 44, 45, 60, 66, 68, 70, 80, 100, and 116 kDa were phosphorylated, and the
levels of phosphorylation were maximum at 30-45 min post-infection
(Fig. 4A). After a 15-min infection of J774 with YSH6000 but not with TK001, tyrosine
phosphorylation of paxillin was detected by immunoprecipitation with
anti-paxillin monoclonal antibody (Fig. 4B). When the
tyrosine-phosphorylated proteins in J774 infected with YSH6000 were
precipitated by anti-PY, proteins corresponding to 66, 68, and 70 kDa
were recognized with the anti-paxillin mAb (Fig. 4C).
Macrophage spreading is thought to involve the tyrosine phosphorylation
of some proteins including c-Cbl (58). Tyrosine phosphorylation of
c-Cbl was also detected at 30 min post-infection with YSH6000, at which
time the level of tyrosine-phosphorylated c-Cbl was 1.5 times higher
than that with TK001 (Fig. 4D). When tyrosine-phosphorylated
proteins in J774 infected with YSH6000 were precipitated with anti-PY,
proteins corresponding to 100 and 116 kDa were recognized with the
anti-c-CbI antibody (Fig. 4E). To see whether the protein
tyrosine phosphorylation in macrophages infected with YSH6000 would be
similar to that induced by other known stimulators that induce membrane
extensions from macrophages (31, 59), the profiles of
tyrosine-phosphorylated proteins induced in J774 were compared with
that by Salmonella infection or PMA stimulation. As shown in
Fig. 4, F and G, the pattern of protein tyrosine
phosphorylation induced by Salmonella and PMA were different
from that by Shigella. Although the 66-kDa protein, which
was identified as paxillin, was strongly phosphorylated by
Shigella, it was not so prominent as compared with the cells stimulated with Salmonella or PMA (Fig. 4, F and
G). Furthermore, the patterns of tyrosine-phosphorylated
proteins in J774 induced by YSH6000 was different from that of
phagocytosis of zymosan opsonized with C3bi (COZ), IgG (IOZ), or bovine
serum albumin (BOZ) (Fig. 4H). These results suggest that
Shigella entry into macrophages stimulates protein tyrosine
phosphorylation, including paxillin and c-Cbl, but that pattern is
rather unique to Shigella invasion.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 4.
Tyrosine phosphorylation of J774
cell proteins upon S. flexneri invasion.
A, samples are from cells infected with YSH6000, TK001, or
uninfected cells. The time of cell lysis after infection is indicated
above the lanes. The tyrosine-phosphorylated
proteins precipitated with 4G10 were separated on 7.5% SDS-PAGE gel
and blotted with RC20. The lower panel shows the proteins
around 45 kDa after a long exposure. Numbers to the
right indicate the molecular weight standards. The
arrows on the left side indicate the
signals specifically increased in cells infected with YSH6000.
B, paxillin in the lysate from cells infected with YSH6000
or TK001 was precipitated with an anti-paxillin mAb. The
tyrosine-phosphorylated proteins and paxillin were detected by RC20 and
anti-paxillin mAb, respectively. C, tyrosine-phosphorylated
proteins or the paxillin in cells infected with YSH6000 for 30 min were
precipitated with 4G10 or anti-paxillin mAb, respectively. The
tyrosine-phosphorylated proteins and paxillin were detected by RC20.
The arrows indicate the paxillin band. D, c-Cbl
in cells infected with YSH6000 or TK001 was precipitated with an
anti-c-Cbl antibody. The tyrosine-phosphorylated proteins and
c-Cbl were detected by RC20 and anti-c-Cbl antibody, respectively.
Signal intensity of the bands was measured by NIH image software. The
lower band of c-Cbl is the truncated version (70). E,
tyrosine-phosphorylated proteins or the c-Cbl in the lysate from the
cells infected with YSH6000 for 30 min were precipitated with 4G10 or
anti-c-Cbl antibody, respectively. RC20 was used in immunoblotting to
detect the tyrosine-phosphorylated proteins. The arrows
shown at the right side of photograph indicate the c-Cbl
band. F and G, tyrosine-phosphorylated proteins
in J774 cell infected with S. typhimurium (F) or
simulated with PMA (G) were analyzed as described in
A. H, tyrosine-phosphorylated proteins in J774 cell
engulfing complement-opsonized zymosan (COZ), IgG-opsonized
zymosan (IOZ), or bovine serum albumin-opsonized zymosan
(BOZ) were analyzed as in A. The lysates were
prepared from cells 15 min after the addition of the zymosans. The
lysate from the cells infected with YSH6000 (wild type) or TK001
(ipaC mutant) for 30 min was used as the positive and
negative controls, respectively.
|
|
Exogenously Added IpaC Can Stimulate Cell Spreading and Uptake of
Bacteria by Macrophage--
To assess the role of IpaC in stimulating
macrophage uptake of Shigella, the ability of the IpaC
protein to induce macrophage spreading was investigated using phase
contrast microscopy with a time-lapse imaging system. Upon addition of
purified IpaC into the external medium at final concentration of 0.5 µM (20 µg/ml), 20-30% of J774 or HMDM cells responded
by extending lamellipodia as early as 2 min after addition. The scale
of lamellipodia was maximum at 5 min, at which the periphery of
extended lamellipodia also showed ruffling (Fig.
5A, arrowheads), although this
was mostly over by 30 min. Fig. 5B shows a typical spreading
of a J774 cell stained with rhodamine-phalloidin, where F-actin
condensation appeared along the leading edge of the lamellipodium (Fig.
5B). When an E. coli strain such as HB101 was
added together with the purified IpaC, uptake by J774 was increased up
to ~1.6-fold that by HB101 alone (Fig. 5C). Under the same
conditions, addition of other purified effector proteins such as IpaD
or VirA had no appreciable effect on bacterial uptake. In contrast to
J774 cells, the addition of the same amount of IpaC as above into the
external medium of HeLa or Caco-2 cells did not stimulate any changes
in cell shape or uptake of HB101 (data not shown). Thus, these results suggest that IpaC has the ability to induce membrane extensions in
macrophages and promote uptake of bacteria by the cell.

View larger version (60K):
[in this window]
[in a new window]
|
Fig. 5.
Induction of macrophage spreading by
histidine-tagged IpaC added into the external medium.
A, IpaC induces lamellipodia and membrane ruffles
(arrowhead) in J774 and HMDM. B,
rhodamine-phalloidin staining of J774 5 min after the addition of IpaC
or buffer. The arrowheads indicate IpaC-induced F-actin-rich
lamellipodia. C, the relative numbers of internalized
bacteria (E. coli HB101) as measured by the phagocytosis
assay. The relative value of 1.0 represents the number in the absence
of IpaC protein. Error bars represent S.E. from triplicate
experiments.
|
|
Functional Domain of IpaC Required for Inducing
Macrophage Spreading--
To determine the functional domain of IpaC
involved in induction of the membrane extensions in macrophages,
various truncated IpaC versions were constructed as the
histidine-tagged proteins (Fig.
6A). Purified truncated IpaC
proteins were checked by SDS-PAGE (Fig. 6B), and equal
amounts of each of protein were added into the external medium of J774,
and the cells were observed using the phase contrast microscopy or
immunostaining with the anti-IpaC-wm antibody. Fig. 6A
summarizes the ability of each IpaC-truncated protein to induce
membrane extensions or associate with the macrophage membrane. Fig.
6C (top) shows a typical cellular response to the addition of a truncated IpaC protein such as C1, which results in
membrane extensions. Addition of C4 and NC could also induce membrane extensions in J774 as large as that caused the full-length IpaC (data not shown). The fluorescence signals for the full-length IpaC and the truncated versions ( C1, C4, and NC) were found associated with the cell membrane (Fig. 6C, top).
Importantly, when the membrane-associated fluorescence signals were
analyzed at the vertical axis, the signals for C1 were found to be
integrated into host plasma membrane detected for membrane-spanning
signals (Fig. 6C), whereas the other IpaC truncated versions
such as CTM or C8 were not associated with the cells at all (data
not shown). Taking these results together it strongly suggest that
the residues encompassing positions 117-169 (see Fig. 4A)
are sufficient for inducing the membrane extensions and the association
with the macrophage membrane.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 6.
The functional domains of IpaC.
A, schematic representation of their construction of
IpaC-truncated proteins and summary of the biological activity in J774.
Shaded portion indicates the predicted hydrophobic region.
B, purified IpaC proteins visualized in Coomassie Brilliant
Blue (CBB)-stained 12% SDS-PAGE gel. The numbers
at the right side represent molecular standards in kDa.
C, detection of membrane-integrated IpaC. Anti-IpaC-wm
antibody (green) and rhodamine-phalloidin (red)
staining of J774 5 min after the addition of C1 into external
medium. The vertical section between the
arrowheads in the upper panel is shown in the
lower panel. Association of IpaC (green) and the
J774 cell membrane was observed at the arrowheads in the
lower panel.
|
|
Topological Analysis of IpaC on the Macrophage Membrane--
For
analysis with TMpred, a program for prediction of putative
membrane-spanning regions (60) in IpaC, the residues encompassing 121-139 and 169-191 were predicted to be putative transmembrane domains, whereas the remaining N-terminal and C-terminal regions would
be present on the external side of the plasma membrane. To determine
the membrane topology of IpaC, three IpaC antibodies (anti-IpaC-n, -m,
and -c), which recognized three distinctive regions in IpaC (see Fig.
7A, top bar), were
purified using synthetic peptides (see "Experimental Procedures").
The resulting anti-IpaC-n, anti-IpaC-m, and anti-IpaC-c antibodies were
found to recognize the N-terminal IpaC portion, a hydrophobic region
bracketed by the two putative transmembrane regions (TM1 and TM2) and a
region following TM2, respectively, by using various truncated IpaC
versions (Fig. 6A) in immunoblotting (data not shown). J774
cells on two coverslips for staining with each antibody were incubated
with purified C1 for 5 min. In the experiment, C1 was used
instead of the full-length IpaC due to the ease in its preparation as compared with the full-length IpaC. After fixation, one of the coverslips was treated with 0.2% Triton X-100 to permeabilize the host
cell membrane, and the other one was not. The cells on both coverslips
were then immunostained with each anti-IpaC antibody. The fluorescent
signal of IpaC stained with the anti-IpaC-m antibody was significantly
decreased in nonpermeabilized cells (Fig. 7A, e) as compared
with that in the permeabilized cell (Fig. 7A, b) or
nonpermeabilized cell stained with the other antibodies (Fig. 7A,
d and f). These data together with the results in Fig.
6 suggest that the residues 140-168 of IpaC exist as the cytoplasmic
loop, whereas the preceding N-terminal portion of TM1 and the following C-terminal portion of TM2 exist as the external membrane domains (Fig.
7B).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 7.
A model for IpaC membrane topology in J774
cells. A, the top bar represents the IpaC
putative transmembrane domains predicted with the TMpred program. The
lower panels show immunostaining of permeabilized
(a-c) or nonpermeabilized (d-f) J774 cell with
anti-IpaC-n (a and d), anti-IpaC-m (b
and e), or anti-IpaC-c (c and f)
antibodies and rhodamine-phalloidin. Fluorescent signal of IpaC
(green) on the cell membrane was significantly decreased in
e. B, a hypothetical model for the IpaC topology including
the IpaC-mediated macrophage spreading system. Tyrosine phosphorylation
of paxillin and c-Cbl might be stimulated by the aggregation of
phagocytic receptors such as Mac-1 or Fc R at the site of bacterial
attachment. The activation of phosphatidylinositol 3-kinase
(PI-3K) might be caused downstream of the phosphorylated
c-Cbl (58). In addition, membrane-integrated IpaC might activate Cdc42
and Rac1 as has been suggested by Tran Van Nhieu et al.
(25), resulting in the triggering of the phagocytic event.
|
|
 |
DISCUSSION |
Shigella infection of the resident macrophages beneath
M cells overlaying the solitary lymphoid nodules in the colon
constitute an early critical infection event. The bacteria released
from the macrophages then basolaterally invade the colonic epithelial cells, whereas the infected macrophages and epithelial cells produce inflammatory mediators, the major cause leading to bacillary dysentery (61). Nevertheless, the strategy for Shigella infection of
macrophages has remained largely speculative. Therefore, in the present
study, we investigated whether Shigella could direct its own
internalization into macrophages, like the case for invasion of
epithelial cells. Our data indicate that Shigella can
initiate its own internalization into macrophages, and the secreted
IpaC protein plays a major role in triggering the phagocytic event.
This conclusion is based on the following results. (i) The efficiency
of invasion of macrophage by wild type S. flexneri was
significantly higher than that by noninvasive mutants. (ii) Infection
of macrophages by wild type S. flexneri but not the
noninvasive mutants induced a large scale membrane extension, including
lamellipodia and membrane ruffles. (iii) The addition of purified IpaC
protein into the external medium of macrophages rapidly induced
membrane extensions and mediated bacteria uptake.
Although the mechanisms underlying the IpaC-mediated cell spreading
event are still to be elucidated, some surface receptors such as Mac-1
on the macrophage might be involved in the phagocytic event. Incubation
of J774 cells with wild type Shigella but not with the
ipaC deletion mutant generated Mac-1 foci at the site of
bacterial attachment as well as along the periphery of the extended
cell membrane, strongly indicating that an
integrin-dependent adhesion event, which is a prominent
feature of the Mac-1-mediated macrophage adherence, had been
stimulated. This observed macrophage response is consistent with the
previous report by Renesto et al. (62), in which PMN
suspended in medium became adherent to culture plates coated with FBS
when wild type S. flexneri but not the ipaC
mutant was added into the external medium.
Previous studies (57, 63-65) have indicated that clustering of Fc R
and Mac-1 stimulate protein tyrosine phosphorylation and local
rearrangement of the actin cytoskeleton, although the tyrosine-phosphorylated proteins vary depending on the cell signaling pathway and the nature of ligands including surface receptors engaged
in phagocytic events (53). Therefore, we investigated the profile of
induced protein tyrosine phosphorylation in J774 infected with wild
type Shigella or ipaC deletion mutant. The results indicated that Shigella infection of macrophages
induced tyrosine phosphorylation of a set of proteins including
paxillin and c-Cbl but that it was rather distinctive from those
induced by Salmonella infection or PMA stimulation (see Fig.
4, E and F). In macrophages and PMN, paxillin is
thought to be tyrosine-phosphorylated in the cell spreading and
adhesion mediated by the M 2 integrin (Mac-1) (56, 59) or phagocytosis mediated by Fc R (55). Tyrosine
phosphorylation of c-Cbl has been thought to be stimulated through
macrophage spreading, for which the integrin bound to an extracellular
matrix such as fibronectin is indicated to be involved in the
interaction of c-Cbl with Src family kinases (58). Overexpression of
c-Cbl in COS-7 cells or macrophages has been shown to stimulate
Fc R-mediated phagocytosis (66). Although the increased level of
c-Cbl tyrosine phosphorylation in J774 during Shigella
infection was marginal, the increase was reproducible in three
independent experiments, suggesting that phosphorylated c-Cbl might
also contribute to Shigella invasion of macrophages. Although tyrosine phosphorylation of some other proteins such as Vav or
Syk has also been found to be stimulated by Fc R-mediated phagocytosis or Mac-1-mediated cell adhesion (55, 65, 67), so far no
proteins other than paxillin and c-Cbl have yet been shown to be
convincingly tyrosine-phosphorylated in J774 cells during
Shigella infection using immunoprecipitation and
immunoblotting assays. Nevertheless, these results lead us to speculate
that the entry into macrophages involves the activation of some
cellular signaling pathways that might be unique to the
Shigella entry process.
In infection of the macrophage by Shigella, we focused on
the role of IpaC, one of the type III secreted proteins, since previous studies (25, 68) indicated that IpaC has the ability to induce actin
reorganization from nonprofessional phagocytic cells such as epithelial
or fibroblastic cells including the activation of Cdc42. Our results
showed that when purified IpaC was added to the external medium of
cells, we observed that only macrophage cells responded quickly to
extend lamellipodium, a reaction that was never observed in
nonprofessional phagocytic cells (25, 68). Indeed, whereas the addition
of the purified IpaC protein into the external medium of epithelial
cells such as HeLa or Caco-2 cells showed no appreciable effect on cell
shape, addition of the IpaC protein into J774 cells promoted uptake of
bacteria such as E. coli HB101.
IpaC has been shown to be composed of three distinctive
domains (25). The first domain is the N-terminal portion encompassing the first residue to residue 116. The second domain is the central hydrophobic portion encompassing residues 117-190. The third domain is
the remaining C-terminal portion. Consistent with a recent report (69)
on epithelial cells, we demonstrated that the central hydrophobic
domain of IpaC is essential for binding to the host plasma membrane.
The experiment to narrow down the functional domain of IpaC indicated
that the central IpaC region encompassing residues 117-169, which
contains one of the putative two membrane-spanning domains, is required
for the association with the host membrane as well as for inducing
macrophage spreading. Indeed, we could directly visualize the IpaC
protein integrated into the macrophage plasma membrane using
immunofluorescence staining. Furthermore, we also determined the
membrane topology of IpaC by immunostaining with three distinctive
anti-IpaC antibodies. Our data strongly indicate that IpaC is
integrated via the two membrane-spanning regions with an ~30-amino
acid cytoplasmic loop, whereas the N- and C-terminal portions exist on
the external side of the plasma membrane (see Fig. 7B).
Since some IpaC truncated versions capable of associating with the host
membrane were able to stimulate macrophage cell spreading, although no
direct evidence has yet been obtained, IpaC might have some association
with or effect on some putative host receptor(s) mediating the
induction of membrane extension via activation of some cellular signal
transduction pathway such as activation of Cdc42 (25). If so, the
macrophage system would be useful for investigating the downstream
signal transduction pathways evoked upon integration of IpaC into the
host membrane.
In summary, our data provide for the first time clear evidence
supporting the idea that Shigella directs its own
invasiveness into macrophages, and the IpaC involved in the invasion of
epithelial cells also appears to be critical for triggering of the
phagocytic event. The information on the distinctive functional
organization of the IpaC domains based on their effect on macrophage
spreading will also provide an important insight into understanding the precise role of IpaC in Shigella pathogenesis.
 |
ACKNOWLEDGEMENTS |
We thank Katsuaki Sato, Masahisa Watarai,
Hiroyuki Abe, Ichiro Tatsuno, and Toru Tobe for helpful discussions. We
also thank the members of Division of Electron Microscopy, School of
Medicine, Juntendo University, for technical assistance with electron
microscopy. We thank Shinobu Imajoh-Ohmi and Takashi Nonaka for helpful advice.
 |
FOOTNOTES |
*
This work was supported by the Research for the Future
Program of the Japan Society for the Promotion of Science and by Grant 11770135 from the Ministry of Education, Science, and Culture of the
Japanese Government.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed. Tel.: 81-3-5449-5252;
Fax: 81-3-5449-5405; E-mail: sasakawa@ims.u-tokyo.ac.jp.
Published, JBC Papers in Press, June 18, 2001, DOI 10.1074/jbc.M103831200
 |
ABBREVIATIONS |
The abbreviations used are:
PMN, polymorphonuclear leukocyte;
HMDM, human monocyte-derived macrophage;
m.o.i., multiplicity of infection;
PBS, phosphate-buffered saline;
mAb, monoclonal antibody;
COZ, complement-opsonized zymosan;
IOZ, IgG-opsonized zymosan;
BOZ, bovine serum albumin-opsonized zymosan;
PMA, phorbol myristate acetate;
PY, phosphotyrosine;
GST, glutathione
S-transferase;
PAGE, polyacrylamide gel electrophoresis;
LPS, lipopolysaccharide.
 |
REFERENCES |
| 1.
|
Wassef, J. S.,
Keren, D. F.,
and Mailloux, J. L.
(1989)
Infect. Immun.
57,
858-863
|
| 2.
|
Sansonetti, P. J.,
Arondel, J.,
Fontaine, A.,
d'Hauteville, H.,
and Bernardini, M. L.
(1991)
Vaccine
9,
416-422
|
| 3.
|
Sansonetti, P. J.,
Arondel, J.,
Cantey, J. R.,
Prevost, M. C.,
and Huerre, M.
(1996)
Infect. Immun.
64,
2752-2764
|
| 4.
|
Zychlinsky, A.,
Prevost, M. C.,
and Sansonetti, P. J.
(1992)
Nature
358,
167-169
|
| 5.
|
Sansonetti, P. J.,
Ryter, A.,
Clerc, P.,
Maurelli, A. T.,
and Mounier, J.
(1986)
Infect. Immun.
51,
461-469
|
| 6.
|
Makino, S.,
Sasakawa, C.,
Kamata, K.,
Kurata, T.,
and Yoshikawa, M.
(1986)
Cell
46,
551-555
|
| 7.
|
Bernardini, M. L.,
Mounier, J.,
d'Hauteville, H.,
Coquis-Rondon, M.,
and Sansonetti, P. J.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
3867-3871
|
| 8.
|
Sasakawa, C.,
Kamata, K.,
Sakai, T.,
Makino, S.,
Yamada, M.,
Okada, N.,
and Yoshikawa, M.
(1988)
J. Bacteriol.
170,
2480-2484
|
| 9.
|
Buchrieser, C.,
Glaser, P.,
Rusniok, C.,
Nedjari, H.,
D'Hauteville, H.,
Kunst, F.,
Sansonetti, P.,
and Parsot, C.
(2000)
Mol. Microbiol.
38,
760-771
|
| 10.
|
Sasakawa, C.,
Adler, B.,
Tobe, T.,
Okada, N.,
Nagai, S.,
Komatsu, K.,
and Yoshikawa, M.
(1989)
Mol. Microbiol.
3,
1191-1201
|
| 11.
|
Sasakawa, C.,
Buysse, J. M.,
and Watanabe, H.
(1992)
Curr. Top. Microbiol. Immunol.
180,
21-44
|
| 12.
|
Parsot, C.
(1994)
Curr. Top. Microbiol. Immunol.
192,
217-241
|
| 13.
|
Menard, R.,
Sansonetti, P.,
Parsot, C.,
and Vasselon, T.
(1994)
Cell
79,
515-525
|
| 14.
|
Menard, R.,
Prevost, M. C.,
Gounon, P.,
Sansonetti, P.,
and Dehio, C.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
1254-1258
|
| 15.
|
Tran Van Nhieu, G.,
and Sansonetti, P. J.
(1999)
Curr. Opin. Microbiol.
2,
51-55
|
| 16.
|
Collazo, C. M.,
and Galan, J. E.
(1997)
Mol. Microbiol.
24,
747-756
|
| 17.
|
Hakansson, S.,
Schesser, K.,
Persson, C.,
Galyov, E. E.,
Rosqvist, R.,
Homble, F.,
and Wolf-Watz, H.
(1996)
EMBO J.
15,
5812-5823
|
| 18.
|
Blocker, A.,
Gounon, P.,
Larquet, E.,
Niebuhr, K.,
Cabiaux, V.,
Parsot, C.,
and Sansonetti, P.
(1999)
J. Cell Biol.
147,
683-693
|
| 19.
|
Watarai, M.,
Funato, S.,
and Sasakawa, C.
(1996)
J. Exp. Med.
183,
991-999
|
| 20.
|
Skoudy, A.,
Mounier, J.,
Aruffo, A.,
Ohayon, H.,
Gounon, P.,
Sansonetti, P.,
and Nhieu, G. T.
(1999)
Cell Microbiol.
2,
19-33
|
| 21.
|
Tran Van Nhieu, G.,
Bourdet-Sicard, R.,
Dumenil, G.,
Blocker, A.,
and Sansonetti, P. J.
(2000)
Cell Microbiol.
2,
187-193
|
| 22.
|
Sansonetti, P. J.
(2001)
FEMS Microbiol. Rev.
25,
3-14
|
| 23.
|
Tran Van Nhieu, G.,
Ben-Ze'ev, A.,
and Sansonetti, P. J.
(1997)
EMBO J.
16,
2717-2729
|
| 24.
|
Bourdet-Sicard, R.,
Rudiger, M.,
Jockusch, B. M.,
Gounon, P.,
Sansonetti, P. J.,
and Nhieu, G. T.
(1999)
EMBO J.
18,
5853-5862
|
| 25.
|
Tran Van Nhieu, G.,
Caron, E.,
Hall, A.,
and Sansonetti, P. J.
(1999)
EMBO J.
18,
3249-3262
|
| 26.
|
Rosqvist, R.,
Magnusson, K. E.,
and Wolf-Watz, H.
(1994)
EMBO J.
13,
964-972
|
| 27.
|
Sory, M. P.,
and Cornelis, G. R.
(1994)
Mol. Microbiol.
14,
583-594
|
| 28.
|
Lee, V. T.,
Anderson, D. M.,
and Schneewind, O.
(1998)
Mol. Microbiol.
28,
593-601
|
| 29.
|
Lee, V. T.,
and Schneewind, O.
(1999)
Immunol. Rev.
168,
241-255
|
| 30.
|
Chen, L. M.,
Kaniga, K.,
and Galan, J. E.
(1996)
Mol. Microbiol.
21,
1101-1115
|
| 31.
|
Alpuche-Aranda, C. M.,
Racoosin, E. L.,
Swanson, J. A.,
and Miller, S. I.
(1994)
J. Exp. Med.
179,
601-608
|
| 32.
|
Hersh, D.,
Monack, D. M.,
Smith, M. R.,
Ghori, N.,
Falkow, S.,
and Zychlinsky, A.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2396-2401
|
| 33.
|
Monack, D. M.,
Raupach, B.,
Hromockyj, A. E.,
and Falkow, S.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9833-9838
|
| 34.
|
Uchiya, K.,
Barbieri, M. A.,
Funato, K.,
Shah, A. H.,
Stahl, P. D.,
and Groisman, E. A.
(1999)
EMBO J.
18,
3924-3933
|
| 35.
|
Brumell, J. H.,
Rosenberger, C. M.,
Gotto, G. T.,
Marcus, S. L.,
and Finlay, B. B.
(2001)
Cell Microbiol.
3,
75-84
|
| 36.
|
Clerc, P. L.,
Ryter, A.,
Mounier, J.,
and Sansonetti, P. J.
(1987)
Infect. Immun.
55,
521-527
|
| 37.
|
Nonaka, T.,
Kuwae, A.,
Sasakawa, C.,
and Imajoh-Ohmi, S.
(1999)
FEMS Microbiol. Lett.
174,
89-95
|
| 38.
|
Fernandez-Prada, C. M.,
Hoover, D. L.,
Tall, B. D.,
and Venkatesan, M. M.
(1997)
Infect. Immun.
65,
1486-1496
|
| 39.
|
Zychlinsky, A.,
Fitting, C.,
Cavaillon, J. M.,
and Sansonetti, P. J.
(1994)
J. Clin. Invest.
94,
1328-1332
|
| 40.
|
Sansonetti, P. J.,
Arondel, J.,
Cavaillon, J. M.,
and Huerre, M.
(1995)
J. Clin. Invest.
96,
884-892
|
| 41.
|
Arondel, J.,
Singer, M.,
Matsukawa, A.,
Zychlinsky, A.,
and Sansonetti, P. J.
(1999)
Infect. Immun.
67,
6056-6066
|
| 42.
|
Sasakawa, C.,
Makino, S.,
Kamata, K.,
and Yoshikawa, M.
(1986)
Infect. Immun.
54,
32-36
|
| 43.
|
Tamano, K.,
Aizawa, S.,
Katayama, E.,
Nonaka, T.,
Imajoh-Ohmi, S.,
Kuwae, A.,
Nagai, S.,
and Sasakawa, C.
(2000)
EMBO J.
19,
3876-3887
|
| 44.
|
Durand, J. M.,
Okada, N.,
Tobe, T.,
Watarai, M.,
Fukuda, I.,
Suzuki, T.,
Nakata, N.,
Komatsu, K.,
Yoshikawa, M.,
and Sasakawa, C.
(1994)
J. Bacteriol.
176,
4627-4634
|
| 45.
|
Tobe, T.,
Yoshikawa, M.,
and Sasakawa, C.
(1994)
Mol. Microbiol.
12,
267-276
|
| 46.
|
Small, P. L.,
Isberg, R. R.,
and Falkow, S.
(1987)
Infect. Immun.
55,
1674-1679
|
| 47.
|
Suzuki, T.,
Miki, H.,
Takenawa, T.,
and Sasakawa, C.
(1998)
EMBO J.
17,
2767-2776
|
| 48.
|
Ginocchio, C. C.,
Olmsted, S. B.,
Wells, C. L.,
and Galan, J. E.
(1994)
Cell
76,
717-724
|
| 49.
|
Menard, R.,
Sansonetti, P. J.,
and Parsot, C.
(1993)
J. Bacteriol.
175,
5899-5906
|
| 50.
|
Van Strijp, J. A.,
Russell, D. G.,
Tuomanen, E.,
Brown, E. J.,
and Wright, S. D.
(1993)
J. Immunol.
151,
3324-3336
|
| 51.
|
Tapper, H.,
and Grinstein, S.
(1997)
J. Immunol.
159,
409-418
|
| 52.
|
Caron, E.,
and Hall, A.
(1998)
Science
282,
1717-1721
|
| 53.
|
Chimini, G.,
and Chavrier, P.
(2000)
Nat. Cell Biol.
2,
E191-E196
|
| 54.
|
May, R. C.,
Caron, E.,
Hall, A.,
and Machesky, L. M.
(2000)
Nat. Cell Biol.
2,
246-8
|
| 55.
|
Greenberg, S.,
Chang, P.,
and Silverstein, S. C.
(1994)
J. Biol. Chem.
269,
3897-3902
|
| 56.
|
Graham, I. L.,
Anderson, D. C.,
Holers, V. M.,
and Brown, E. J.
(1994)
J. Cell Biol.
127,
1139-1147
|
| 57.
|
Berton, G.,
Fumagalli, L.,
Laudanna, C.,
and Sorio, C.
(1994)
J. Cell Biol.
126,
1111-1121
|
| 58.
|
Meng, F.,
and Lowell, C. A.
(1998)
EMBO J.
17,
4391-4403
|
| 59.
|
Li, J.,
Zhu, Z.,
and Bao, Z.
(1996)
J. Biol. Chem.
271,
12985-12990
|
| 60.
|
Hofmann, K.,
and Stoffel, W.
(1993)
Biol. Chem. Hoppe-Seyler
374,
166
|
| 61.
|
Sansonetti, P. J.
(1998)
Folia Microbiol.
43,
239-246
|
| 62.
|
Renesto, P.,
Mounier, J.,
and Sansonetti, P. J.
(1996)
Infect. Immun.
64,
719-723
|
| 63.
|
Yan, S. R.,
Huang, M.,
and Berton, G.
(1997)
J. Immunol.
158,
1902-1910
|
| 64.
|
Ninomiya, N.,
Hazeki, K.,
Fukui, Y.,
Seya, T.,
Okada, T.,
Hazeki, O.,
and Ui, M.
(1994)
J. Biol. Chem.
269,
22732-22737
|
| 65.
|
Kiefer, F.,
Brumell, J.,
Al-Alawi, N.,
Latour, S.,
Cheng, A.,
Veillette, A.,
Grinstein, S.,
and Pawson, T.
(1998)
Mol. Cell. Biol.
18,
4209-4220
|
| 66.
|
Sato, N.,
Kim, M. K.,
and Schreiber, A. D.
(1999)
J. Immunol.
163,
6123-6131
|
| 67.
|
Zheng, L.,
Sjolander, A.,
Eckerdal, J.,
and Andersson, T.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
8431-8436
|
| 68.
|
Tran, N.,
Serfis, A. B.,
Osiecki, J. C.,
Picking, W. L.,
Coye, L.,
Davis, R.,
and Picking, W. D.
(2000)
Infect. Immun.
68,
3710-3715
|
| 69.
|
Picking, W. L.,
Coye, L.,
Osiecki, J. C.,
Barnoski Serfis, A.,
Schaper, E.,
and Picking, W. D.
(2001)
Mol. Microbiol.
39,
100-111
|
| 70.
|
Blake, T. J.,
and Langdon, W. Y.
(1992)
Oncogene
7,
757-762
|
Copyright © 2001 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
G. N. Schroeder and H. Hilbi
Molecular Pathogenesis of Shigella spp.: Controlling Host Cell Signaling, Invasion, and Death by Type III Secretion
Clin. Microbiol. Rev.,
January 1, 2008;
21(1):
134 - 156.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. N. Schroeder, N. J. Jann, and H. Hilbi
Intracellular type III secretion by cytoplasmic Shigella flexneri promotes caspase-1-dependent macrophage cell death
Microbiology,
September 1, 2007;
153(9):
2862 - 2876.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Kuwae, T. Matsuzawa, N. Ishikawa, H. Abe, T. Nonaka, H. Fukuda, S. Imajoh-Ohmi, and A. Abe
BopC Is a Novel Type III Effector Secreted by Bordetella bronchiseptica and Has a Critical Role in Type III-dependent Necrotic Cell Death
J. Biol. Chem.,
March 10, 2006;
281(10):
6589 - 6600.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Suzuki, K. Nakanishi, H. Tsutsui, H. Iwai, S. Akira, N. Inohara, M. Chamaillard, G. Nunez, and C. Sasakawa
A Novel Caspase-1/Toll-like Receptor 4-independent Pathway of Cell Death Induced by Cytosolic Shigella in Infected Macrophages
J. Biol. Chem.,
April 8, 2005;
280(14):
14042 - 14050.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
W. L. Picking, H. Nishioka, P. D. Hearn, M. A. Baxter, A. T. Harrington, A. Blocker, and W. D. Picking
IpaD of Shigella flexneri Is Independently Required for Regulation of Ipa Protein Secretion and Efficient Insertion of IpaB and IpaC into Host Membranes
Infect. Immun.,
March 1, 2005;
73(3):
1432 - 1440.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Lucchini, H. Liu, Q. Jin, J. C. D. Hinton, and J. Yu
Transcriptional Adaptation of Shigella flexneri during Infection of Macrophages and Epithelial Cells: Insights into the Strategies of a Cytosolic Bacterial Pathogen
Infect. Immun.,
January 1, 2005;
73(1):
88 - 102.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Kueltzo, J. Osiecki, J. Barker, W. L. Picking, B. Ersoy, W. D. Picking, and C. R. Middaugh
Structure-Function Analysis of Invasion Plasmid Antigen C (IpaC) from Shigella flexneri
J. Biol. Chem.,
January 24, 2003;
278(5):
2792 - 2798.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. J. Hathaway, G. E. Griffin, P. J. Sansonetti, and J. D. Edgeworth
Human Monocytes Kill Shigella flexneri but Then Die by Apoptosis Associated with Suppression of Proinflammatory Cytokine Production
Infect. Immun.,
July 1, 2002;
70(7):
3833 - 3842.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Noda, H. Sagara, E. Suzuki, A. Takada, H. Kida, and Y. Kawaoka
Ebola Virus VP40 Drives the Formation of Virus-Like Filamentous Particles Along with GP
J. Virol.,
April 16, 2002;
76(10):
4855 - 4865.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2001 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|